Grant: Alliance Grants
McMaster University
$50,000.00
A simple and rapid point-of-care (POC) test for SARS-CoV-2_x000d_
EF 2020-21
Résumé
There is presently an urgent need to increase the diagnostic testing capability for COVID-19 (SARS-CoV-2) in Canada and elsewhere. However, currently approved tests, as well as those in the pipeline, suffer from one or more deficiencies, such as competition for crucial biological reagents, high false-negative rates, cost, poor user-friendliness, or limited availability in Canada. In addition, current testing methods, which rely on sample collection using a swab, followed by the shipping of swabs to a central testing facility, are plagued by very long delays. The goal of this proposal is to develop a rapid point-of-care test for SARS-CoV-2 based on a novel RNA processing method and an isothermal amplification technique, coupled to a paper sensing device. The test will utilize a novel DNAzyme to excise RNA from the virus, followed by rolling circle amplification to amplify the RNA and convert the output to a long DNA strand. The DNA output will be enriched on a paper device that is capable of generating a color change if the virus is present in the test sample. The simplicity of the test will allow it to be done at home, in airports or other points-of-entry, or on cruise ships, and will allow "sample-to-answer" in under an hour, with no need to visit an external testing location. This will reduce the burden on front-line workers and centralized labs, while minimizing exposure of potentially infected patients to the community. Such tests will also make it easier to identify asymptomatic carriers, will allow for more rapid testing of potential contacts, and ultimately help to contain future outbreaks at an earlier stage, thus reducing the potential time needed for physical distancing measures.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
554880-2020
Name nom
Li, Yingfu
Department département
Biochemistry and Biomedical Sciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
A simple and rapid point-of-care (POC) test for SARS-CoV-2_x000d_
Keyword
NSERC
Application summary
There is presently an urgent need to increase the diagnostic testing capability for COVID-19 (SARS-CoV-2) in Canada and elsewhere. However, currently approved tests, as well as those in the pipeline, suffer from one or more deficiencies, such as competition for crucial biological reagents, high false-negative rates, cost, poor user-friendliness, or limited availability in Canada. In addition, current testing methods, which rely on sample collection using a swab, followed by the shipping of swabs to a central testing facility, are plagued by very long delays. The goal of this proposal is to develop a rapid point-of-care test for SARS-CoV-2 based on a novel RNA processing method and an isothermal amplification technique, coupled to a paper sensing device. The test will utilize a novel DNAzyme to excise RNA from the virus, followed by rolling circle amplification to amplify the RNA and convert the output to a long DNA strand. The DNA output will be enriched on a paper device that is capable of generating a color change if the virus is present in the test sample. The simplicity of the test will allow it to be done at home, in airports or other points-of-entry, or on cruise ships, and will allow "sample-to-answer" in under an hour, with no need to visit an external testing location. This will reduce the burden on front-line workers and centralized labs, while minimizing exposure of potentially infected patients to the community. Such tests will also make it easier to identify asymptomatic carriers, will allow for more rapid testing of potential contacts, and ultimately help to contain future outbreaks at an earlier stage, thus reducing the potential time needed for physical distancing measures.